TerminatedPhase 2NCT01471054
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Arman Mashayekhi
- Principal Investigator
- Armen Mashayekhi, MDWills Eye Hospital IRB Director
- Intervention
- Ozurdex(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2015
Study locations (1)
- Ocular Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania, United States
Collaborators
Allergan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01471054 on ClinicalTrials.govOther trials for Cystoid macular dystrophy
Additional recruiting or active studies for the same condition.